Today’s investment in ID research; public health and prevention; and development of new drugs, vaccines and diagnostics will pay significant dividends in the future. Such investments can prevent needless deaths, dramatically reduce health care costs, and improve the quality of life for millions of Americans and others around the world. IDSA supports appropriate funding for domestic and international programs including those at the:
- National Institute of Allergy and Infectious Diseases
- Centers for Disease Control and Prevention
- Food and Drug Administration
- Health Resources and Services Administration
- U.S. Agency for International Development
- National Institutes of Health’s Fogarty International Center
IDSA’s funding priorities include antimicrobial resistance; immunizations; drug, vaccine and diagnostics development; and HIV/AIDS and tuberculosis prevention and treatment.